The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Always finish with sunscreen during daytime
Research progress regarding the effect and mechanism of dietary phenolic acids for improving nonalcoholic fatty liver disease via gut microbiota
W., Kema, I
We ensure all our products are third-party tested and made in GMP-aligned facilities
In addition levels of toxic intracellular sulphite increase (ASD 107 nmol/ml, NT 2.1 nmol/ml) as well as thiosulfate (ASD 131 nmol/ml, NT 19 nmol/ml) (Kruithof et al, 2020)